Latest Non Dilutive Funding News

Vection Technologies has locked in $1.2 million in non-repayable government funding to advance four distinct R&D projects spanning AI, Extended Reality, digital health, and inclusive technology.

Altamin Limited has locked in a $2 million unsecured loan facility from its major shareholder Victor Smorgon Group, providing non-dilutive funding to advance its Lazio and Gorno projects and shore up working capital.

Tusker Minerals has inked a binding deal to sell its Machinga Rare Earth Elements project in Malawi to AuKing Mining for up to A$4 million, freeing capital to concentrate on its high-grade rutile and heavy mineral sands assets.

Iondrive Limited has independently confirmed strong rare earth recoveries from U.S. magnet waste and gained Oklahoma government support for its first commercial processing module, advancing its U.S. commercialisation strategy.

Mont Royal Resources has released an updated Preliminary Economic Assessment for its Ashram Rare Earths and Fluorspar Project, outlining robust economics and a 30-year mine life. High-grade fluorspar at the nearby Mallard Prospect adds strategic by-product potential as the company advances towards a Pre-Feasibility Study.

Godolphin Resources has unveiled a significant polymetallic sulphide discovery at Cousin Jack within its Lewis Ponds Project, alongside progressing an IPO to spin out its Narraburra Rare Earths asset into Matrix Critical Minerals.

Talga Group has marked a milestone with its first commercial delivery of natural graphite anode outside Asia, progressing key funding discussions and strategic partnerships to support its Vittangi Anode Project.

Dimerix Limited (ASX: DXB) has inked its fifth regional licensing agreement with Everest Medicines, boosting potential milestone payments to A$1.9 billion and expanded its kidney disease pipeline through the acquisition of DMX-652. The Phase 3 ACTION3 trial for DMX-200 remains statistically robust, with funding secured to advance both clinical programs.

HITIQ Limited has fortified its financial position through a $1.4 million placement and secured milestone-based Victorian Government funding, accelerating its manufacturing expansion and commercial growth in concussion management technology.

Everest Metals is set to begin toll processing at its Mt Dimer Gold Project in September 2026, backed by strong mining progress and promising high-grade drill results.

Antipa Minerals has upgraded its Minyari Project resource to 3.6 million ounces gold equivalent with a strong increase in indicated resources, while launching a major 41,000m drilling campaign and advancing its Pre-Feasibility Study with encouraging metallurgical and geotechnical results.

Argenica Therapeutics is gearing up for a pivotal late-stage clinical trial of its neuroprotective drug ARG-007 (xaranetide) in acute ischaemic stroke, backed by strong safety assays and solid funding.